Nomura Asset Management Co. Ltd. boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,816 shares of the company’s stock after acquiring an additional 373 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Henry Schein were worth $2,830,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC increased its holdings in Henry Schein by 15.0% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 40,512 shares of the company’s stock valued at $2,597,000 after buying an additional 5,299 shares during the period. Blue Trust Inc. increased its holdings in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. TCW Group Inc. raised its position in shares of Henry Schein by 72.6% in the 2nd quarter. TCW Group Inc. now owns 24,740 shares of the company’s stock worth $1,586,000 after acquiring an additional 10,407 shares in the last quarter. Raymond James & Associates lifted its stake in shares of Henry Schein by 2.0% during the 2nd quarter. Raymond James & Associates now owns 292,166 shares of the company’s stock worth $18,728,000 after purchasing an additional 5,763 shares during the last quarter. Finally, First Citizens Bank & Trust Co. boosted its position in Henry Schein by 12.6% during the second quarter. First Citizens Bank & Trust Co. now owns 49,993 shares of the company’s stock valued at $3,205,000 after purchasing an additional 5,585 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have commented on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reiterated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI upped their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Seven equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $78.89.
Insider Activity at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by insiders.
Henry Schein Stock Down 0.6 %
Henry Schein stock opened at $76.60 on Friday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a market cap of $9.55 billion, a PE ratio of 31.52, a PEG ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business’s 50-day simple moving average is $72.25 and its two-hundred day simple moving average is $70.06.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period last year, the firm posted $1.32 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Special Dividend?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Using the MarketBeat Dividend Tax Calculator
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.